Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Virology

• Publication date

  2004-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.78.9.4638-4645.2004PMID 15078946PMCID PMC387705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA Vaccines

  2006cited by this paper
• Enhancing DNA Vaccine Potency by Combining a Strategy to Prolong Dendritic Cell Life with Intracellular Targeting Strategies 1

  2003cited by this paper
• Coronavirus as a possible cause of severe acute respiratory syndrome

  2003cited by this paper
• A novel coronavirus associated with severe acute respiratory syndrome.

  2003cited by this paper
• Aetiology: Koch's postulates fulfilled for SARS virus

  2003cited by this paper
• The Genome Sequence of the SARS-Associated Coronavirus

  2003cited by this paper
• Antibody-Dependent Enhancement of Virus Infection and Disease

  2003cited by this paper
• Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan

  2003cited by this paper
• Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

  2003cited by this paper
• Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

  2003influential reference
• SARS coronavirus: a new challenge for prevention and therapy.

  2003cited by this paper
• Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

  2003cited by this paper
• Improving DNA vaccine potency via modification of professional antigen presenting cells.

  2003cited by this paper
• Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

  2003cited by this paper
• Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever

  2002cited by this paper
• Cancer Immunotherapy Using Sindbis Virus Replicon Particles Encoding a VP22–Antigen Fusion

  2002cited by this paper
• Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.

  2001cited by this paper
• Improving DNA Vaccines Targeting Viral Infection

  2001cited by this paper
• Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.

  2000cited by this paper
• Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.

  2000cited by this paper
• Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry.

  2000cited by this paper
• Calreticulin, a Peptide-binding Chaperone of the Endoplasmic Reticulum, Elicits Tumor- and Peptide-specific Immunity

  1999cited by this paper
• DNA vaccines.

  1997cited by this paper
• TAP‐translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin

  1997cited by this paper
• Dendritic cells: unique leukocyte populations which control the primary immune response.

  1997cited by this paper
• Origin, maturation and antigen presenting function of dendritic cells.

  1997cited by this paper
• Nucleic acid vaccines: an overview.

  1997cited by this paper
• The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection

  1997cited by this paper
• Dendritic Cells: Unique Leukocyte Populations Which Control the Primary

  1997cited by this paper
• Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP.

  1996cited by this paper
• DNA–based immunization by in vivo transfection of dendritic cells

  1996cited by this paper
• Coronavirus-induced encephalomyelitis: balance between protection and immune pathology depends on the immunization schedule with spike protein S.

  1995cited by this paper
• Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

  1995cited by this paper
• Heat Shock-sensitive Expression of Calreticulin.

  1995cited by this paper
• Calreticulin: not just another calcium-binding protein

  1994cited by this paper
• Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein

  1993cited by this paper
• Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain

  1993cited by this paper
• Mouse hepatitis virus nucleocapsid protein-specific cytotoxic T lymphocytes are Ld restricted and specific for the carboxy terminus

  1992cited by this paper
• Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus.

  1991cited by this paper
• The dendritic cell system and its role in immunogenicity.

  1991cited by this paper

• Nanoparticle-mediated enhancement of DNA Vaccines: Revolutionizing immunization strategies.

  2025cites this paper
• Combination of S1-N-Terminal and S1-C-Terminal Domain Antigens Targeting Double Receptor-Binding Domains Bolsters Protective Immunity of a Nanoparticle Vaccine against Porcine Epidemic Diarrhea Virus.

  2024cites this paper
• Immunization against Medically Important Human Coronaviruses of Public Health Concern

  2024cites this paper
• Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses

  2024cites this paper
• Combination of Recombinant Proteins S1/N and RBD/N as Potential Vaccine Candidates

  2023cites this paper
• Synergistic Immunity and Protection in Mice by Co-Immunization with DNA Vaccines Encoding the Spike Protein and Other Structural Proteins of SARS-CoV-2

  2023cites this paper
• Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19

  2022cites this paper
• The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19?

  2022influential citation
• RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System

  2022cites this paper
• SARS‐CoV‐2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective

  2022cites this paper
• Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug

  2022cites this paper
• SARS-CoV-2: Pathophysiology, Prophylaxis and Treatment Opportunities – A Current Review

  2022cites this paper
• Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies

  2022cites this paper
• Promising COVID-19 Vaccines

  2021cites this paper
• Considerations for bioanalytical characterization and batch release of COVID-19 vaccines

  2021cites this paper
• The variants of SARS‐CoV‐2 and the challenges of vaccines

  2021cites this paper
• Current advances in the development of SARS-CoV-2 vaccines

  2021cites this paper
• COVID-19 vaccine: where are we now and where should we go?

  2021cites this paper
• Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients

  2021cites this paper
• Nanotechnology enabled management approaches against the Covid-19 pandemic

  2021cites this paper
• Concept of SARS-CoV-2 Vaccine Design to Fight COVID-19 Pandemic: A Review Insight

  2021cites this paper
• Vaccine Development and Immune Responses in COVID-19: Lessons from the Past

  2021cites this paper
• Infection with Avian Coronaviruses: A recurring problem in turkeys

  2021cites this paper
• Peptides Derived From S and N Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Induce T Cell Responses: A Proof of Concept for T Cell Vaccines

  2021cites this paper
• Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine

  2021cites this paper
• Vaccine design and delivery approaches for COVID-19

  2021cites this paper
• Analysis of COVID‐19 vaccines: Types, thoughts, and application

  2021cites this paper
• Comparative research on nucleocapsid and spike glycoprotein as the rapid immunodetection targets of COVID-19 and establishment of immunoassay strips

  2021cites this paper
• Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients

  2021cites this paper
• Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)

  2021cites this paper
• Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19

  2021cites this paper
• COVID-19: Recent Developments in Therapeutic Approaches

  2021cites this paper
• TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID‐19 patients

  2021cites this paper
• Updates of COVID-19

  2021cites this paper
• Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate

  2020cites this paper
• Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19

  2020cites this paper
• Lessons Learned from SARS-CoV and MERS-CoV: Preparation for SARS-CoV-2 induced COVID-19

  2020cites this paper
• Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2

  2020cites this paper
• Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2

  2020cites this paper
• Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development

  2020cites this paper
• Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies

  2020cites this paper
• Coronavirus vaccine development: from SARS and MERS to COVID-19

  2020cites this paper
• Review of Viral Testing (Polymerase Chain Reaction) and Antibody/Serology Testing for Severe Acute Respiratory Syndrome-Coronavirus-2 for the Intensivist

  2020cites this paper
• Alternative vaccine delivery methods

  2020cites this paper
• Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review

  2020cites this paper
• Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)

  2020cites this paper
• Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

  2020cites this paper
• Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine

  2020cites this paper
• Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma

  2020cites this paper
• Vaccination strategies to combat novel corona virus SARS-CoV-2

  2020cites this paper
• In reply—The “Perfect Cytokine Storm” of COVID-19

  2020cites this paper
• Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis

  2020cites this paper
• Progress and Prospects on Vaccine Development against SARS-CoV-2

  2020cites this paper
• The “Perfect Cytokine Storm” of COVID-19

  2020cites this paper
• Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2

  2020cites this paper
• Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity

  2020cites this paper
• A systematic review of SARS-CoV-2 vaccine candidates

  2020cites this paper
• Epitope-Based Peptide Vaccine Against Severe Acute Respiratory Syndrome-Coronavirus-2 Nucleocapsid Protein: An in silico Approach

  2020cites this paper
• COVID-19 vaccines: The status and perspectives in delivery points of view

  2020cites this paper
• The mysterious of SARS and mers vaccines, new approaches to a coronavirus vaccine. (Covid-19 özel sayi.) [Turkish]

  2020cites this paper
• Greater Protection against Virulent Infectious Bronchitis Virus Challenge Conferred by Recombinant Baculovirus Co-expressing S 1 and N Proteins

  2018cites this paper
• Protection against Virulent Infectious Bronchitis Virus Challenge Conferred by a Recombinant Baculovirus Co-Expressing S1 and N Proteins

  2018cites this paper
• Technologies to Improve Immunization

  2017cites this paper
• Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection

  2016cites this paper
• Nucleocapsid proteins: roles beyond viral RNA packaging

  2016influential citation
• Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination

  2015cites this paper
• DNA Mediated Vaccines Delivery Through Nanoparticles.

  2015cites this paper
• Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein

  2015cites this paper
• The Coronavirus Nucleocapsid Is a Multifunctional Protein

  2014cites this paper
• Applications of nanoparticles for DNA based rabies vaccine.

  2014cites this paper
• Nanoparticles for DNA vaccine delivery.

  2014cites this paper
• Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells

  2014cites this paper
• High-Level Protein Expression Following Single and Dual Gene Cloning of Infectious Bronchitis Virus N and S Genes Using Baculovirus Systems

  2014cites this paper
• Identification of two ATR-dependent phosphorylation sites on coronavirus nucleocapsid protein with nonessential functions in viral replication and infectivity in cultured cells

  2013cites this paper
• Experimental SARS and influenza: similar disease, different pathways

  2013cites this paper
• Animal models in virus research: their utility and limitations

  2013cites this paper
• Calreticulin as a hydrophilic chimeric molecular adjuvant enhances IgG responses to the spike protein of severe acute respiratory syndrome coronavirus

  2012cites this paper
• Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen

  2012cites this paper
• Development of a DNA vaccine targeting Merkel cell polyomavirus.

  2012cites this paper
• Understanding the T cell immune response in SARS coronavirus infection

  2012cites this paper
• Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.

  2012cites this paper
• Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines

  2011cites this paper
• Cloning and characterization of the human coronavirus NL63 nucleocapsid protein

  2011cites this paper
• [Recent developments in SARS vaccine studies].

  2010cites this paper
• Construction and characterization of calreticulin-HBsAg fusion gene recombinant adenovirus expression vector.

  2010cites this paper
• Molecular biology of the SARS-coronavirus

  2010cites this paper
• Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination

  2010cites this paper
• An oral mucosal DNA vaccine for SARS coronavirus infections.

  2009cites this paper
• Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice

  2009cites this paper
• Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice

  2009influential citation
• Targeting and retention of HPV16 E7 to the endoplasmic reticulum enhances immune tumour protection

  2009cites this paper
• The Nucleocapsid Protein of the SARS Coronavirus: Structure, Function and Therapeutic Potential

  2009cites this paper
• SARS vaccines: where are we?

  2009cites this paper
• Antibody Binding Site Mapping of SARS-CoV Spike Protein Receptor-Binding Domain by a Combination of Yeast Surface Display and Phage Peptide Library Screening

  2009cites this paper
• Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model

  2009cites this paper
• Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine

  2008cites this paper
• Enhancement of Antibody Responses to Bacillus anthracis Protective Antigen Domain IV by Use of Calreticulin as a Chimeric Molecular Adjuvant

  2008cites this paper
• A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus

  2008cites this paper
• Structure, Immunopathogenesis and Vaccines Against SARS Coronavirus

  2008cites this paper
• Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects

  2008cites this paper